2013
DOI: 10.1038/eye.2013.240
|View full text |Cite
|
Sign up to set email alerts
|

Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro

Abstract: Purpose Retinal hypoxia-mediated activation of the hypoxia-inducible factor (HIF pathway) leading to angiogenesis is a major signaling mechanism underlying a number of sight-threatening diseases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
25
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(26 citation statements)
references
References 40 publications
0
25
0
1
Order By: Relevance
“…HIF-1α levels are subject to complex translational controls operating through nutrient and cellular energy-sensing mTOR complexes [28], and VEGF production is partially dependent on mTORC1-induced HIF-1α expression [29]. As shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…HIF-1α levels are subject to complex translational controls operating through nutrient and cellular energy-sensing mTOR complexes [28], and VEGF production is partially dependent on mTORC1-induced HIF-1α expression [29]. As shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Hypoxia occurs secondary to a number of disease processes in the human body (9). In response to hypoxia, retinal pigment epithelial cells (RPE cells) rapidly release various growth factors resulting in angiogenesis, fibrovascular tissue formation and retinal ablation (10). Among the hypoxia-stimulated growth factors, vascular endothelial growth factor (VEGF), a potent vascular endothelial cell mitogen, is a pivotal regulator of vasculogenesis and angiogenesis in CNV (11).…”
Section: Introductionmentioning
confidence: 99%
“…Aside from the previously mentioned angiogenic inhibitors, a variety of alternative mechanisms of action and gene transfer therapies are currently under investigation, such as targeting vascular endothelial receptor tyrosine kinase [37], overexpressed integrins [38], hypoxia-induced activator [39] or metalloproteinases [40], among others [41]. Notwithstanding the potential of these strategies, only preliminary studies have been conducted and the possible adverse effects on normal choroidal vessels and retinal neurons remain to be evaluated [27,42].…”
Section: Drug Delivery To the Posteriors Segment Of The Eyementioning
confidence: 98%